The invention relates to tyrosine kinase inhibitors of the bis-indolyl compound type of the general formula I:
1
pharmaceuticals containing them and their use for the treatment of malignant and other diseases based on pathological cell proliferation.
本发明涉及一种通式I的双
吲哚基
酪氨酸激酶
抑制剂,以及含有它们的药物,以及它们用于治疗基于病理细胞增殖的恶性和其他疾病的用途。